Amid Setbacks In Field, Boston Alzheimer’s Researcher Forges Ahead With Immunotherapy Trials – WBUR
WBUR |
Amid Setbacks In Field, Boston Alzheimer’s Researcher Forges Ahead With Immunotherapy Trials
WBUR Alzheimer’s disease unravels the minds of those who get it. It can tear apart the fabric of families that struggle with it. And it costs this nation billions of dollars — an estimated $259 billion per year ($175 billion of that spent by Medicare and … |
Scicasts (press release) (blog) |
Blood Test Could Indicate Which Patients Will Respond to Immunotherapy
Scicasts (press release) (blog) London, UK (Scicasts) — A test that measures the levels of two types of immune cell in the blood could identify which cancer patients are most likely to respond to immunotherapy. The test gives a measure of a patient’s immune system health by … |
fox6now.com |
‘There is promise:’ Groundbreaking cancer treatment gives hope to terminal patients
fox6now.com Years of chemotherapy, stem cell transplants and treatments passed before Carroll was presented with chimeric antigen receptor T (CAR–T) cell therapy. It was developed in the last five years. Doctors take a patient’s T cells and re-engineer them. “In … Wisconsin cancer patient becomes first in world to undergo breakthrough treatmentWTMJ-TV (press release) (blog) |